Retraction: The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis (PLoS ONE (2012) 7:12 (e50919) DOI: 10.1371/journal.pone.0050919);The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Zhang, Qing ^a   Chen, Xinguo ^a   Zang, Yunjin ^a   Zhang, Li ^c   Chen, Hong ^a   Wang, Letian ^a   Niu, Yujian ^a   Ren, Xiuyun ^a   Shen, Zhongyang ^a   Shang, Lei ^b  

^a GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Shaanxi Provincial Corps Hospital of Chinese People's Armed Police Force   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN A; ENTECAVIR; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; VIRUS DNA;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; FEMALE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC SHOCK; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG INFECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PROTEIN BLOOD LEVEL; SEPSIS; TUMOR VOLUME; UNIVARIATE ANALYSIS;

EID: 84870879013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0222176     Document Type: Erratum

References (50)

1. World Health Organization. (2009) Hepatitis B: Surveillance and control. http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index4.html. Accessed October 23.
2. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, et al. (2004) Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38 (10 Suppl 3): S158-168.
3. Liu J, Fan D, (2007) Hepatitis B in China. Lancet 369 (9573): 1582-1583.
4. McMahon BJ, (2009) The natural history of chronic hepatitis B virus infection. Hepatology 49 (5 Suppl): S45-55.
5. Xu J, Lin Y, Wang YP, Chen YX, Shi B, et al. (2009) Hepatitis B virus DNA in patients with hepatitis B-related liver cirrhosis with or without hepatocellular carcinomas: a matched case-control study. J Dig Dis 10 (2): 138-144.
6. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, et al. (1993) Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218 (2): 145-151.
7. Hertl M, Cosimi AB, (2005) Liver transplantation for malignancy. Oncologist 10 (4): 269-281.
8. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (11): 693-699.
9. Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, et al. (1998) Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma:a retrospective analysis. Ann Surg 227 (3): 424-432.
10. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, et al. (2003) Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 238 (4): 508-518; discussion 518-509.
11. Bechstein WO, Blumhardt G, Lobeck H, Keck H, Lemmens HP, et al. (1994) Selection of small hepatocellular carcinoma improves long-term results of hepatic transplantation for malignancy. Transpl Int 7 (Suppl 1):: S238-240.
12. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, et al. (1991) Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214 (3): 221-228; discussion 228-229.
13. Sutcliffe R, Maguire D, Portmann B, Rela M, Heaton N, (2006) Selection of patients with hepatocellular carcinoma for liver transplantation. Br J Surg 93 (1): 11-18.
14. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, et al. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33 (6): 1394-1403.
15. Romani F, Belli LS, Rondinara SF, De Carlis L, Rimoldi P, et al. (1994) The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver. J Am Coll Surg 178: 379-384.
16. Figueras J, Jaurrieta E, Valis C, Benasco C, Rafecas A, et al. (1997) Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 25: 1485-1489.
17. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, et al. (1998) Liver transplantation for small hepatocellular carcinoma: the Tumor-Node-Metastasis classification does not have prognostic power. Hepatology 27: 1572-1577.
18. Marsh JW, Dvorchik I, Subotin M, Balan V, Rakela J, et al. (1997) The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 26 (2): 444-450.
19. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, et al. (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10 (1): 35-43.
20. Cescon M, Ravaioli M, Grazi GL, Ercolani G, Cucchetti A, et al. (2010) Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular. J Transplant 2010: 9041-9052.
21. Chu F, Morris DL, (2006) Single centre experience of liver resection for hepatocellular carcinoma in patients outside transplant criteria. Eur J Surg Oncol 32 (5): 568-572.
22. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, et al. (2001) Liver transplantation for hepatocellular carcinoma. Ann Surg 233 (5): 652-659.
23. Huitzil-Melendez F-D, Capanu M, O'Reilly EM, Duffy A, Gansukh B, et al. (2010) Abou-Alfa. Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis? American Society of Clinical Oncology 28 (17): 2889-2895.
24. DuBay D, Sandroussi C, Sandhu L, Cleary S, Guba M, et al. (2011) Advanced Hepatocellular Carcinoma: tumor Staging,. Ann Surg 253 (1): 166-172.
25. Wong SN, Reddy KR, Keeffe EB, Han SH, Gaglio PJ, et al. (2007) Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma. Liver Transpl 13 (3): 334-342.
26. Dan YY, Wai CT, Yeoh KG, Lim SG, (2006) Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis. Liver Transpl 12 (5): 736-746.
27. Wong SN, Reddy KR, Keeffe EB, Han SH, Gaglio PJ, et al. (2007) Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma. Liver Transpl 13 (3): 334-342.
28. Dan YY, Wai CT, Yeoh KG, Lim SG, (2006) Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis. Liver Transpl 12 (5): 736-746.
29. Yao FY, Terrault NA, Freise C, Maslow L, Bass NM, (2001) Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 34 (2): 411-416.
30. Steinmuller T, Seehofer D, Rayes N, Müller AR, Settmacher U, et al. (2002) Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 35 (6): 1528-1535.
31. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, et al. (2002) Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 8 (9): 765-774.
32. Gondolesi GE, Roayaie S, Munoz L, Kim-Schluger L, Schiano T, et al. (2004) Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 239 (2): 142-149.
33. Cillo U, Vitale A, Volk ML, Brolese A, Zanus G, et al. (2010) The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis 42 (9): 642-649.
34. Ishizaki Y, Kawasaki S, (2008) The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol 43 (1): 18-26.
35. Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, et al. (2009) Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transpl 15 (11): 1525-1534.
36. Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ, (2003) The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 21 (23): 4329-4335.
37. Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, et al. (2007) Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B. Transplant Proc 39 (10): 3276-3280.
38. Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, et al. (2009) Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transpl 15 (11): 1525-1534.
39. Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, et al. (2009) Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience. Arch Surg 144 (10): 906-913.
40. Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ, (2003) The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 21 (23): 4329-4335.
41. Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, et al. (2007) Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B. Transplant Proc 39 (10): 3276-3280.
42. Marsh JW, Dvorchik I, Iwatsuki S, (2000) UNOS' policy in upgrading patients with HCC a waiting liver transplantation: too little too late [Abstract]. Transplantation 69 (Suppl): S139.
43. Tan KC, Rela M, Ryder SD, Rizzi PM, Karani J, et al. (1995) Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma less than 8 cmin patients with cirrhosis. Br J Surg 82: 253-256.
44. McPeake JR, O'Grady JG, Zaman S, Portmann B, Wight DG, et al. (1993) Liver transplantation for primary hepatocellular carcinoma:tumor size and number determine outcome. J Hepatol 18: 226-234.
45. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, et al. (2003) Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 237 (4): 536-543.
46. Poon RT, Fan ST, Lo CM, Liu CL, Wong J, (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Sur 235 (3): 373-382.
47. Forman LM, Lucey MR, (2001) Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology 33 (2): 473-475.
48. Chen MF, Tsai HP, Jeng LB, Lee WC, Yeh CN, et al. (2003) Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg 27 (4): 443-447.
49. Park UJ, Kim YH, Kang KJ, Lim TJ, (2008) Risk factors for early recurrence after surgical resection for hepatocellular carcinoma. Korean J Hepatol 14 (3): 371-380.
50. Workman P, Kaye SB, (2002) Translating basic cancer research into new cancer therapeutics. Trends Mol Me 8 (4 Suppl): S1-9.